Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A team of researchers led by Duke University, the University of California San Francisco, and the Beckman Research Institute ...

Phase 1a results support further development of TX000045 (“TX45”) for Group 2 Pulmonary Hypertension in HFpEF (“PH-HFpEF”), based on favorable pharmacokinetic profile and ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei ...

Nxera will hold an exclusive licence for the antibody assets globally, granting full rights for their development and ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Tectonic Therapeutic Inc ( (TECX) ) has released its Q3 earnings. Here is a breakdown of the information Tectonic Therapeutic Inc presented to ...